Gilder Gagnon Howe & Co’s Axogen AXGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-24,713
Closed -$287K 338
2020
Q3
$287K Sell
24,713
-2,227
-8% -$25.9K ﹤0.01% 293
2020
Q2
$249K Hold
26,940
﹤0.01% 271
2020
Q1
$280K Sell
26,940
-1,162,253
-98% -$14.8M ﹤0.01% 232
2019
Q4
$21.3M Buy
1,189,193
+743,871
+167% +$11M 0.22% 98
2019
Q3
$5.56M Sell
445,322
-119,020
-21% -$1.96M 0.06% 161
2019
Q2
$11.2M Buy
564,342
+122,491
+28% +$2.62M 0.11% 125
2019
Q1
$9.3M Sell
441,851
-11,516
-3% -$210K 0.1% 129
2018
Q4
$9.26M Sell
453,367
-70,901
-14% -$2.22M 0.13% 115
2018
Q3
$19.3M Sell
524,268
-71,797
-12% -$3.13M 0.2% 102
2018
Q2
$30M Buy
596,065
+650
+0.1% +$28.6K 0.32% 74
2018
Q1
$21.7M Buy
595,415
+61,104
+11% +$1.87M 0.27% 88
2017
Q4
$15.1M Sell
534,311
-29,727
-5% -$701K 0.2% 97
2017
Q3
$10.9M Sell
564,038
-4,086
-0.7% -$68.7K 0.15% 117
2017
Q2
$9.52M Buy
568,124
+8,608
+2% +$116K 0.14% 119
2017
Q1
$5.85M Buy
559,516
+117,178
+26% +$1.2M 0.1% 135
2016
Q4
$3.98M Buy
+442,338
New +$3.81M 0.08% 132

Other funds holding AXGN

Gilder Gagnon Howe & Co's AXGN Position: Q4 2020 in Review

Gilder Gagnon Howe & Co sold out of Axogen (AXGN) in Q4 2020, closing a stake of 24,713 shares — an estimated $287K sold.

Gilder Gagnon Howe & Co first reported a position in AXGN in Q4 2016 and held it in 16 quarters. The position peaked at $30M in Q2 2018. 121 funds tracked by Wall St. Rank hold AXGN as of Q4 2020.

  • Gilder Gagnon Howe & Co reported no remaining Axogen position as of Q4 2020 after selling out during the quarter.
  • Gilder Gagnon Howe & Co sold 24,713 Axogen shares in Q4 2020, an estimated $287K.
  • Gilder Gagnon Howe & Co first reported a position in Axogen in Q4 2016 and held it in 16 quarters.
  • Gilder Gagnon Howe & Co's Axogen position peaked at $30M in Q2 2018.
  • 121 funds tracked by Wall St. Rank held Axogen as of Q4 2020.

Based on Gilder Gagnon Howe & Co's 13F filing for Q4 2020, filed 16 Feb 2021.